Continuous Glucose Monitoring (CGM) in an Underserved Population

About this trial

Last updated 14 days ago

Study ID

2024-1872

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

Accepting

18 to 75 Years

All Sexes

Trial Timing

Started 2 months ago

What is this trial about?

The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide better care for an underserved population. This will be a pilot study to evaluate the feasibility of such a trial in this population before doing a larger multicenter trial.

What are the participation requirements?

Inclusion Criteria

* Age 18-75 years

* Type 2 diabetes mellitus

* HbA1C ≥ 7.5%

* At least on 1 insulin injection therapy daily

* Patients established with primary care clinic or endocrinology clinic or diabetes clinics in the New Orleans and surrounding areas

* Patients with Medicaid or free care or uninsured

* Patients must be able to speak and understand English and be capable of providing informed consent to participate in the study

Exclusion Criteria

* Type 1 diabetes mellitus

* Currently on CGM or using insulin pump

* Advanced renal disease or Estimated Glomerular Filtration Rate (eGFR) <40

* Serious co-morbidities which in the investigator's opinion, will make it challenging for patients to participate

* The patient has been diagnosed with end-stage renal disease, is on dialysis, or has had a kidney transplant, Hemoglobinopathies, iron therapy or other condition that interferes with HbA1c measurement

* Pregnant